Gupta K

151P Maintenance Therapy using Tyrosine Kinase Inhibitor (erlotinib) or Pemetrexed in metastatic/locally advanced in EGFR Mutation-Negative Lung Cancer: Comparison of Results - 2018 -

No Abstract


Lung Cancer
Pemetrexed
EGFR Mutation-Negative

Powered by Koha